Follow The Filings

EXPO Exponent Inc.

Industrials, filed as EXPONENT INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.0%
  • $21M
  • 1 reduce

In 2026 Q2 Ron Baron trimmed Exponent.

Who owns this now

Largest portfolio weights among holders, up to 0.0% (Ron Baron, Bamco Inc. (Baron Capital)). Not free-float ownership.

  1. Ron Baron Reduce 0.03%

Who owns EXPO

Sorted by value, long equity only, as of 2026 Q2.

History
Ron Baron, Bamco Inc. (Baron Capital) 0.03%, was 0.10% Reduce −26.7% 364,297 $21M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by EXPO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All EXPO insider trades
  • $13K bought by 1 insider
  • $795K sold by 5 insiders outside a trading plan
  • $2.2M sold by 1 insider under 10b5-1 plans
  1. Shukri Jeries Souri Group Vice President
    Buy
    $13K 184 shares at $68.45 +0.5% to stake
    Traded Sep 18 Filed Sep 22
    ↗
  2. Catherine Corrigan CEO
    Planned sale
    $113K 1,707 shares at $66.28 1.3% of stake
    Traded Aug 17 Filed Aug 18
    ↗
  3. Catherine Corrigan CEO
    Planned sale
    $109K 1,737 shares at $62.78 1.5% of stake
    Traded Jul 15 Filed Jul 17
    ↗
  4. Catherine Corrigan CEO
    Planned sale
    $235K 4,119 shares at $57.13 3.7% of stake
    Traded Jun 15 Filed Jun 17
    ↗
  5. Bradley A James Group Vice President
    Sale
    $115K 2,000 shares at $57.47 64% of stake
    Traded May 26 Filed May 27
    ↗
  6. Richard Reiss Group Vice President
    Sale
    $98K 1,672 shares at $58.65 42% of stake
    Traded May 19 Filed May 19
    ↗
  7. Catherine Corrigan CEO
    Planned sale
    $227K 4,194 shares at $54.06 3.8% of stake
    Traded May 15 Filed May 15
    ↗
  8. Joseph Rakow Group Vice President
    Sale
    $161K 2,945 shares at $54.66 100% of stake
    Traded May 13 Filed May 13
    ↗
  9. Joseph Sala Group Vice President
    Sale
    $117K 2,066 shares at $56.66 100% of stake
    Traded May 13 Filed May 13
    ↗
  10. Catherine Corrigan CEO
    Planned sale
    $529K 7,821 shares at $67.59 7% of stake
    Traded Mar 16–Apr 15 Filed Apr 16
    ↗
  11. Catherine Corrigan CEO
    Planned sale
    $263K 3,920 shares at $67.15 4% of stake
    Traded Feb 17 Filed Feb 18
    ↗
  12. John Pye VP Global Offices & Innovation
    Sale
    $304K 4,000 shares at $75.97 14% of stake
    Traded Feb 10 Filed Feb 12
    ↗
  13. Catherine Corrigan CEO
    Planned sale
    $121K 1,663 shares at $72.52 1.8% of stake
    Traded Jan 15 Filed Jan 20
    ↗
  14. Catherine Corrigan CEO
    Planned sale
    $228K 3,225 shares at $70.74 3.7% of stake
    Traded Dec 15, 2025 Filed Dec 16, 2025
    ↗
  15. Catherine Corrigan CEO
    Planned sale
    $345K 4,900 shares at $70.39 5.5% of stake
    Traded Nov 17, 2025 Filed Nov 18, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 33 option exercises, 8 share withholdings for taxes, and 1 gift.

Congress

2 members of Congress traded EXPO in the last three years: 3 buys and 2 sales. 1 member listed it in 2025 annual reports.

All Congress trades
  1. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Sep 11, 2025 filed Oct 22, 2025
  2. Lisa C. McClain R-MI-9Spouse Buy $1K–$15K Aug 13, 2025 filed Sep 12, 2025
  3. Jefferson Shreve R-IN-6 Sell $15K–$50K May 12, 2025 filed Jun 22, 2025
  4. Jefferson Shreve R-IN-6 Buy $15K–$50K Mar 13, 2025 filed Apr 11, 2025
  5. Jefferson Shreve R-IN-6 Buy $15K–$50K Feb 24, 2025 filed Mar 9, 2025

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2025
Revenue $536.77M $558.51M
Net income $100.34M $109M
Net margin * 18.7% 19.5%

Balance sheet

Metric FY2023 FY2025
Total current assets $379.53M $446.88M
Total non-current assets * $267.24M $330.39M
Total assets $646.78M $777.27M
Total current liabilities $161.91M $163.18M
Total non-current liabilities * $128.78M $193.02M
Total equity $356.08M $421.07M

Cash flow

Metric FY2023 FY2025
Cash from operations $127.35M $144.54M
Cash from investing -$16.36M -$6.94M
Cash from financing -$86.01M -$65.11M
Net change in cash $25.69M $71.75M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.